San Diego, CA -- (SBWIRE) -- 05/07/2019 -- An investor, who purchased shares of Indivior PLC (OTC: INVVY), filed a lawsuit over alleged violations of Federal Securities Laws by Indivior PLC.

Investors who purchased shares of Indivior PLC (OTC: INVVY) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2019. OTC: INVVY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. On April 9, 2019, the U.S. Department of Justice announced that a federal grand jury had indicted Indivior Inc. and Indivior PLC "for engaging in an illicit nationwide scheme to increase prescriptions of Suboxone Film, an opioid drug used in the treatment of opioid addiction…" According to a DOJ press release, Indivior is accused of obtaining "billions of dollars in revenue from Suboxone Film prescriptions by deceiving health care providers and health care benefit programs into believing that Suboxone Film was safer, less divertible, and less abusable than other opioid-addiction treatment drugs."

The plaintiff claims that between March 10, 2015 and April 9, 2019, the defendants made false and/or misleading statements and/or failed to disclose that Indivior and its executives engaged in an illicit nationwide scheme to increase prescriptions of Suboxone Film, that Indivior illegally obtained billions of dollars in revenue from Suboxone Film prescriptions by deceiving health care providers and health care benefit programs, that as a result of the aforementioned misconduct, Indivior would face felony charges, and that due to the foregoing, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Indivior PLC (OTC: INVVY) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.